Celldex Therapeutics
Clinical trials sponsored by Celldex Therapeutics, explained in plain language.
-
New shot could stop Cold-Triggered hives in their tracks
Disease control CompletedThis study tested an experimental drug called barzolvolimab (CDX-0159) in 196 adults with chronic hives caused by cold or scratching. Participants still had symptoms despite taking standard antihistamines. The goal was to see if the drug could prevent hives from forming during a …
Phase: PHASE2 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New drug shows promise for swallowing disorder
Disease control CompletedThis study tested a drug called barzolvolimab in 86 adults with active eosinophilic esophagitis, a condition that makes swallowing difficult. The goal was to see if the drug could reduce certain immune cells in the esophagus and ease symptoms. Participants received either the dru…
Phase: PHASE2 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New drug CDX-622 passes first safety check in healthy people
Knowledge-focused CompletedThis early-stage study tested the safety of a new drug called CDX-622 in 85 healthy adults aged 18 to 55. Participants received either the drug or a placebo, and researchers monitored for side effects, drug levels in the blood, and changes in certain body chemicals. The goal was …
Phase: PHASE1 • Sponsor: Celldex Therapeutics • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC